These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32727487)

  • 21. Amyloid-β and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus.
    Herukka SK; Rummukainen J; Ihalainen J; von Und Zu Fraunberg M; Koivisto AM; Nerg O; Puli LK; Seppälä TT; Zetterberg H; Pyykkö OT; Helisalmi S; Tanila H; Alafuzoff I; Hiltunen M; Rinne J; Soininen H; Jääskeläinen JE; Leinonen V
    J Alzheimers Dis; 2015; 46(1):261-9. PubMed ID: 25720406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisterno-lumbar gradient of complement fractions in geriatric patients with suspected normal pressure hydrocephalus.
    Seele J; Kirschfink M; Djukic M; Lange P; Gossner J; Bunkowski S; Wiltfang J; Nau R
    Clin Chim Acta; 2018 Nov; 486():1-7. PubMed ID: 30003878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension.
    Bergman J; Burman J; Bergenheim T; Svenningsson A
    J Neurol; 2021 Feb; 268(2):651-657. PubMed ID: 32901316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy.
    Salzer J; Svenningsson R; Alping P; Novakova L; Björck A; Fink K; Islam-Jakobsson P; Malmeström C; Axelsson M; Vågberg M; Sundström P; Lycke J; Piehl F; Svenningsson A
    Neurology; 2016 Nov; 87(20):2074-2081. PubMed ID: 27760868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular-based diagnosis of multiple sclerosis and its progressive stage.
    Barbour C; Kosa P; Komori M; Tanigawa M; Masvekar R; Wu T; Johnson K; Douvaras P; Fossati V; Herbst R; Wang Y; Tan K; Greenwood M; Bielekova B
    Ann Neurol; 2017 Nov; 82(5):795-812. PubMed ID: 29059494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSF proteome in multiple sclerosis subtypes related to brain lesion transcriptomes.
    Elkjaer ML; Nawrocki A; Kacprowski T; Lassen P; Simonsen AH; Marignier R; Sejbaek T; Nielsen HH; Wermuth L; Rashid AY; Høgh P; Sellebjerg F; Reynolds R; Baumbach J; Larsen MR; Illes Z
    Sci Rep; 2021 Feb; 11(1):4132. PubMed ID: 33603109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
    Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
    Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary progressive multiple sclerosis: cerebrospinal fluid considerations.
    Freedman MS
    Mult Scler; 2004 Jun; 10 Suppl 1():S31-4; discussion S34-5. PubMed ID: 15218807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.
    Romme Christensen J; Börnsen L; Khademi M; Olsson T; Jensen PE; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Jun; 19(7):877-84. PubMed ID: 23178691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between Flow Oscillations and Biochemical Parameters in the Cerebrospinal Fluid.
    Puy V; Zmudka-Attier J; Capel C; Bouzerar R; Serot JM; Bourgeois AM; Ausseil J; Balédent O
    Front Aging Neurosci; 2016; 8():154. PubMed ID: 27445797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.
    Augutis K; Axelsson M; Portelius E; Brinkmalm G; Andreasson U; Gustavsson MK; Malmeström C; Lycke J; Blennow K; Zetterberg H; Mattsson N
    Mult Scler; 2013 Apr; 19(5):543-52. PubMed ID: 23069872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy.
    Elovaara I; Ukkonen M; Leppäkynnäs M; Lehtimäki T; Luomala M; Peltola J; Dastidar P
    Arch Neurol; 2000 Apr; 57(4):546-51. PubMed ID: 10768630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Primary progressive multiple sclerosis: a treatment turns out to be finally effective].
    Lalive PH
    Rev Med Suisse; 2016 Mar; 12(508):472-3. PubMed ID: 27089606
    [No Abstract]   [Full Text] [Related]  

  • 34. Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis.
    Ratzer R; Iversen P; Börnsen L; Dyrby TB; Romme Christensen J; Ammitzbøll C; Madsen CG; Garde E; Lyksborg M; Andersen B; Hyldstrup L; Sørensen PS; Siebner HR; Sellebjerg F
    Mult Scler; 2016 Jun; 22(7):926-34. PubMed ID: 26432857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective Analysis of Cerebrospinal Fluid Profiles in 228 Patients with Leptomeningeal Carcinomatosis : Differences According to the Sampling Site, Symptoms, and Systemic Factors.
    Shim Y; Gwak HS; Kim S; Joo J; Shin SH; Yoo H
    J Korean Neurosurg Soc; 2016 Nov; 59(6):570-576. PubMed ID: 27847569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy.
    Rambeck B; Jürgens UH; May TW; Pannek HW; Behne F; Ebner A; Gorji A; Straub H; Speckmann EJ; Pohlmann-Eden B; Löscher W
    Epilepsia; 2006 Apr; 47(4):681-94. PubMed ID: 16650134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
    Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
    J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.
    Komori M; Matsuyama Y; Nirasawa T; Thiele H; Becker M; Alexandrov T; Saida T; Tanaka M; Matsuo H; Tomimoto H; Takahashi R; Tashiro K; Ikegawa M; Kondo T
    Ann Neurol; 2012 May; 71(5):614-23. PubMed ID: 22522477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.
    Iacobaeus E; Ryschkewitsch C; Gravell M; Khademi M; Wallstrom E; Olsson T; Brundin L; Major E
    Mult Scler; 2009 Jan; 15(1):28-35. PubMed ID: 18805840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher Orexin A levels in lumbar compared to ventricular CSF: a study in idiopathic normal pressure hydrocephalus.
    Kalamatianos T; Markianos M; Margetis K; Bourlogiannis F; Stranjalis G
    Peptides; 2014 Jan; 51():1-3. PubMed ID: 24172541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.